Kalle Gehring, PhD, is a professor of biochemistry at McGill University, Montreal, Canada. His laboratory uses biophysical methods to study proteins involved in neurodegenerative diseases with a focus on the link between neurodegeneration, mitochondria and the ubiquitin system. He has been studying Parkin since 2007 and has published peer-reviewed studies on its structure, activity and involvement in Parkinson’s disease. He founded the Quebec/Eastern Canada Regional NMR Centre and the McGill Centre for Structural Biology. He is also part of PROTEO, a Quebec Network for Research on Protein Function, Engineering, and Applications. Dr. Gehring earned his doctorate from the University of California, Berkeley. His papers in Science and the Nature Structural Molecular Biology have garnered considerable attention with invitations to present at Cold Spring Harbor Laboratory, EMBO and Keystone Symposia meetings.